Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
Immunology and Allergy Clinics of North America
|
May 4, 2013
Aspirin desensitization in aspirin-exacerbated respiratory disease
Andrew A White, Donald D Stevenson
Immunology and Allergy Clinics of North America
|
May 4, 2013
A dedication to Andrew Szczeklik, MD
Donald D Stevenson, Marek L Kowalski
Immunology and Allergy Clinics of North America
|
October 8, 2016
Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease
Donald D Stevenson, Andrew A White
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
February 11, 2005
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors
Ronald A Simon, Donald D Stevenson
The Journal of Allergy and Clinical Immunology
|
August 26, 2009
Hydroxyurea in the treatment of Churg-Strauss syndrome
Rachel U Lee, Donald D Stevenson
Expert Review of Respiratory Medicine
|
November 8, 2016
Current complications and treatment of aspirin-exacerbated respiratory disease
Kevin A Cook, Donald D Stevenson
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 30, 2004
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization
M Pilar Berges-Gimeno, Donald D Stevenson
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 5, 2011
Aspirin-exacerbated respiratory disease: is it in our DNA?
Jinny Chang, Ronald A Simon, Donald D Stevenson
Arthritis and Rheumatism
|
September 5, 2002
The safety of celecoxib in patients with aspirin-sensitive asthma
Katharine M Woessner, Ronald A Simon, Donald D Stevenson
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
Andrew A White, Donald D Stevenson, Ronald A Simon
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
Immunology and Allergy Clinics of North America
|
May 4, 2013
Aspirin desensitization in aspirin-exacerbated respiratory disease
Andrew A White, Donald D Stevenson
Immunology and Allergy Clinics of North America
|
May 4, 2013
A dedication to Andrew Szczeklik, MD
Donald D Stevenson, Marek L Kowalski
Immunology and Allergy Clinics of North America
|
October 8, 2016
Clinical Characteristics of Aspirin-Exacerbated Respiratory Disease
Donald D Stevenson, Andrew A White
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
February 11, 2005
Cross-reactivity of cyclooxygenase 2 inhibitors in patients with a history of cutaneous reactions to cyclooxygenase 1 inhibitors
Ronald A Simon, Donald D Stevenson
The Journal of Allergy and Clinical Immunology
|
August 26, 2009
Hydroxyurea in the treatment of Churg-Strauss syndrome
Rachel U Lee, Donald D Stevenson
Expert Review of Respiratory Medicine
|
November 8, 2016
Current complications and treatment of aspirin-exacerbated respiratory disease
Kevin A Cook, Donald D Stevenson
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 30, 2004
Nonsteroidal anti-inflammatory drug-induced reactions and desensitization
M Pilar Berges-Gimeno, Donald D Stevenson
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
April 5, 2011
Aspirin-exacerbated respiratory disease: is it in our DNA?
Jinny Chang, Ronald A Simon, Donald D Stevenson
Arthritis and Rheumatism
|
September 5, 2002
The safety of celecoxib in patients with aspirin-sensitive asthma
Katharine M Woessner, Ronald A Simon, Donald D Stevenson
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
November 11, 2005
The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease
Andrew A White, Donald D Stevenson, Ronald A Simon
Page
of 6